mCSPC
For mCSPC, Abiraterone Plus ADT and Docetaxel Improves rPFS
In men with de novo metastatic castration-sensitive prostate cancer, the addition of abiraterone (Zytiga, Janssen) ...
SEPTEMBER 2, 2021
Xtandi Granted New Indication: Metastatic Castration-Sensitive Prostate Cancer
The FDA has approved the use of enzalutamide (Xtandi, Pfizer/Astellas) for the treatment of patients with ...
DECEMBER 18, 2019
Load more